Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans. - Wikidata - wikimedia - TriplyDB

Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.

Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.

http://www.wikidata.org/entity/Q33886277

about

Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.Cannabis and psychosis/schizophrenia: human studies Gone to Pot - A Review of the Association between Cannabis and Psychosis Cannabinoids and psychosis Cognitive motor deficits in cannabis users Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D2-induced formation of anandamide Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.Adolescent cannabis use increases risk for cocaine-induced paranoia.The effects of cannabinoids on serum cortisol and prolactin in humans.Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.Impact of Cannabis Use on the Development of Psychotic Disorders How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia.Cannabinoid modulation of cortical adrenergic receptors and transporters.Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.Cannabinoids and Schizophrenia: Risks and Therapeutic Potential Acute effects of THC on time perception in frequent and infrequent cannabis users Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum.Amelioration of the haloperidol-induced memory impairment and brain oxidative stress by cinnarizine.From drugs to deprivation: a Bayesian framework for understanding models of psychosis.The effects of Δ9-tetrahydrocannabinol on the dopamine system.Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure.A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.From real-world events to psychosis: the emerging neuropharmacology of delusions.Central nervous system effects of haloperidol on THC in healthy male volunteers.Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study.-NMDA R/+VDR pharmacological phenotype as a novel therapeutic target in relieving motor-cognitive impairments in Parkinsonism.The role of pre-junctional D2 -like receptors mediating quinpirole-induced inhibition of the vasodepressor sensory CGRPergic out-flow in pithed rats.Does olanzapine inhibit the psychomimetic effects of Δ⁹-tetrahydrocannabinol?Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability.Are deficits in cognition associated with psychotic-like experiences after cannabis?The safety of studies with intravenous Δ⁹-tetrahydrocannabinol in humans, with case histories.Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans.Endocannabinoids and Schizophrenia.

P2860

Q21132308-2C25F115-8669-49F0-BCA4-79316E63E237 Q24602238-3DFC3B66-7682-4890-8D03-317F4B686E0C Q24628837-DB9A090C-40BB-43BF-BBA8-6949413ED91C Q26865311-97F56C74-D036-4531-89DB-1CF56DDC13C4 Q28241328-0B31C4AF-14BF-4F12-A74E-134FD22725CD Q28385443-A07019C7-2AE3-4480-9DA8-2C487C87356F Q28972550-6B292CD2-D0A4-4B69-B634-BC875A923F70 Q30377901-6B6AC0C9-A927-4EA9-BB31-0BF802AB84A7 Q33653144-5844019B-842A-4FD3-82F2-79F2E10EB875 Q33824661-B67A5FB8-42D8-409B-BE21-0286A45CD446 Q34067376-6AA62BAB-E2DA-4922-8968-4F6881EEB8ED Q34257459-58985BFB-CEDC-4E0F-8AEE-F3980E28D712 Q34304341-77ECCADB-D9B4-4AE3-9858-4F6C3B6266E5 Q34509725-45330FE8-19DC-4D0A-A1AF-F956E100B4A5 Q34668606-406AF434-74BD-4516-A846-ACB23396201A Q35096538-5A45C5CC-FDC1-46DF-86FB-C8B551CF1AD3 Q35754854-4469F379-1AC8-46F6-B56B-EE682A8DF3E6 Q35982323-A324C665-DE64-4DE7-89B5-2AA9E8B64A79 Q36157669-7595F5DE-A3D3-4211-A46B-B72658AF071F Q36636653-13F658FD-7C4F-4953-B962-1F2910089066 Q36672926-BA112EA3-EC5D-444F-BA07-786D4D7F316C Q36751811-0E9B11C7-6449-4A8C-86DB-01E33722F891 Q37172823-DBB666D4-5D1F-438B-A195-4EF674FA8D2F Q37370306-2758F643-0A1E-45D6-897D-DCAD0CB2ACD9 Q37441554-7B2DECAD-147D-4401-ABDF-A6CC9064D2BF Q37470412-2DBD60AE-6A6A-488B-9048-CA7480964027 Q37529127-326E6072-968E-4F2F-B31F-323EC4DCB165 Q37530729-FC817DE1-697C-4E52-BC30-A0561CD79EE3 Q41479982-D6001893-94D3-4741-AE74-32D144112BCA Q43168358-A7E9CC65-B0E7-422E-B41C-9EF1181D404A Q44790762-038A4A4E-583D-4EA1-9E33-A507A0AC2281 Q46449896-7314FEAF-4AC1-4E50-80C6-A51D05A9037D Q46905541-050E37A8-6B79-4798-9D7C-DE59E5DC44DE Q49217905-F816BC52-14B0-4BDD-9B5C-BC69528413EF Q50082799-9B64B737-C0F3-4509-9765-B876AD89FC77 Q50476151-9B27520C-B167-4690-BC7E-D612C0B56972 Q50615303-8B3A8932-90DD-4822-B990-934D2BCFC1B0 Q52616960-8B1480DE-F679-48D0-AB13-8A2143F91980 Q55452539-ACE16550-DC2D-4E54-AAA6-7DE39DB3DC38

P2860

Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.

http://www.wikidata.org/entity/Q33886277

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Effects of haloperidol on the ...... etrahydrocannabinol in humans.

@ast

Effects of haloperidol on the ...... etrahydrocannabinol in humans.

@en

type

label

Effects of haloperidol on the ...... etrahydrocannabinol in humans.

@ast

Effects of haloperidol on the ...... etrahydrocannabinol in humans.

@en

prefLabel

Effects of haloperidol on the ...... etrahydrocannabinol in humans.

@ast

Effects of haloperidol on the ...... etrahydrocannabinol in humans.

@en

P1433

Q33886277-F84A7B85-08C4-4C6B-AF77-91842B653D7A

P1476

Q33886277-62721D90-307A-42A7-9036-A0783E7AD993

P2093

Q33886277-45FBEFAD-B656-4E2E-AC6C-63197C2E3F7D

Q33886277-55893180-9A3F-42AB-958A-D8FA002387C3

Q33886277-5F63E12A-0520-4255-822B-01495AD172FD

Q33886277-63119B5F-11FE-4183-8398-32075D19C007

Q33886277-6D6E96C3-C71D-4E83-96EE-B61711EE5EE0

Q33886277-752EE2B2-1D45-4D21-B890-11A82A0C8C0F

Q33886277-753D7167-20FC-42CA-AAC7-0F6E086593AC

Q33886277-A1F5450E-BD8B-464E-B474-C82FD5917B2D

Q33886277-A800487C-3414-4278-8C36-590149D4C27D

Q33886277-ADA69CB2-50C6-42A1-8DFB-E5673D042B28

P2860

Q33886277-04599701-BACE-481F-B30D-DA9AF263323B

Q33886277-04A75A58-44C2-4F25-91E1-51F68A61E48D

Q33886277-072949B3-E571-4A83-BC1B-A4F20BC57085

Q33886277-0C0A7AF6-23C4-49D2-831E-D57C5EC6F451

Q33886277-0F6F38FE-504D-46BE-B6FA-54E648705574

Q33886277-16088901-ADF5-47FB-98C9-D4A977AE4E82

Q33886277-2170238F-BF9F-4CB8-9F9F-C146DA107D4A

Q33886277-2177FB3B-B3B1-417A-8F3F-165C67B77665

Q33886277-2180B63F-E0DA-4224-816D-15DF4D3CEA37

Q33886277-22AA1B88-B97B-4F1C-B186-97FCEBAA6A37

P2888

Q33886277-5B6A3CD7-AA69-4F7B-B03F-6AB2C65056CE

P304

Q33886277-E633E8F9-8EE8-4F31-9482-10D7DA849BA7

P31

Q33886277-9E8486D3-8E56-4B6D-853E-A0D0DF3C1362

P356

Q33886277-12DB9407-45B4-45FC-88B5-43CC7053A88C

P433

Q33886277-D111E538-B25D-4C64-AF24-E22FAE3FA9B8

P478

Q33886277-2FB1C3B9-D4FA-4C70-ACD7-EFBEA9988D5B

P577

Q33886277-DA73D4C2-59D3-409E-8A07-965FA860B17D

P5875

Q33886277-C50EC622-7186-4651-A31B-9B0B8DB0609E

P6179

Q33886277-047BC458-A417-4C09-9709-F15A9944AE13

P698

Q33886277-E0DD2D26-EC9F-4FC0-9751-51856AF47821

P921

Q33886277-0AAADD1F-7F28-4CFD-80ED-B2A78CABE358

Q33886277-A47E5B46-500C-4B97-A7B7-61EF828DD332

P932

Q33886277-E3BD5069-8B58-44D5-8F90-88139B83EF33

P356

S00213-007-1042-2

P1433

Psychopharmacology

P1476

Effects of haloperidol on the ...... etrahydrocannabinol in humans.

@en

P2093

Brian Pittman

http://www.w3.org/2001/XMLSchema#string

Deepak Cyril D'Souza

http://www.w3.org/2001/XMLSchema#string

Edward Perry

http://www.w3.org/2001/XMLSchema#string

Gabriel Braley

http://www.w3.org/2001/XMLSchema#string

Michael Vendetti

http://www.w3.org/2001/XMLSchema#string

Mohini Ranganathan

http://www.w3.org/2001/XMLSchema#string

Rebecca Blaise

http://www.w3.org/2001/XMLSchema#string

Savita Bhakta

http://www.w3.org/2001/XMLSchema#string

Stephen Oliver

http://www.w3.org/2001/XMLSchema#string

Thomas Cooper

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for drug-induced akathisia

The acute effects of cannabinoids on memory in humans: a review

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys.

Marijuana effects on human forgetting functions

The time course and significance of cannabis withdrawal.

Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.

P2888

s00213-007-1042-2

P304

587-603

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-007-1042-2

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

226514373

http://www.w3.org/2001/XMLSchema#string

P6179

1032613494

http://www.w3.org/2001/XMLSchema#string

P698

18228005

http://www.w3.org/2001/XMLSchema#string

P921

tetrahydrocannabinol

P932

2878815

http://www.w3.org/2001/XMLSchema#string